<DOC>
	<DOC>NCT02500212</DOC>
	<brief_summary>Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.</brief_summary>
	<brief_title>Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Recipients of a kidney transplant from a deceased donor or a living donor Recipient of any transplanted organ other than a kidney; Recipients of a bone marrow or stem cell transplant; Recipients of a kidney from a cardiac death donor; Recipients of a kidney from an ABO incompatible donor;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>